Abstract
This review recapitulates the recent knowledge accumulation on overgrowth syndrome related to gain of function of the phosphoinositide3 kinase (PI3K)-alpha. These disorders, known as PIK3CA related overgrowth syndromes (PROS) are caused by somatic PIK3CA mutation occurring during embryogenesis. We summarize here the currently available animal models and new treatments undergoing development.
Author supplied keywords
Cite
CITATION STYLE
APA
Venot, Q., & Canaud, G. (2021). PIK3CA-related overgrowth spectrum: Animal model and drug discovery. Comptes Rendus - Biologies. Academie des sciences. https://doi.org/10.5802/CRBIOL.50
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free